Benlysta® Treatment Requires Certification
Posted 10/19/11

Benlysta® (belimumab) is a new intravenous medication used to treat lupus in adults. HealthChoice requires providers to obtain certification through its Health Care Management Division before beginning treatment with this medication.

To certify treatment with this medication, providers must complete and submit a Benlysta® Request Form for approval. This form is available on the provider section of this website.